Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
37.1M
-
Shares change
-
-1.56M
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
-$54.5M
-
Put/Call ratio
-
0.53
-
Number of buys
-
99
-
Number of sells
-
-137
-
Price
-
$28.65
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q4 2024
288 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q4 2024.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.1M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.56M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.64M shares), Rubric Capital Management LP (2.35M shares), VANGUARD GROUP INC (2.28M shares), Pacer Advisors, Inc. (2.14M shares), Invesco Ltd. (1.78M shares), RENAISSANCE TECHNOLOGIES LLC (1.66M shares), PRINCIPAL FINANCIAL GROUP INC (1.65M shares), STATE STREET CORP (1.44M shares), and FULLER & THALER ASSET MANAGEMENT, INC. (1.35M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.